Clinical Research Trials
Only one FDA-approved medication, riluzole, has been demonstrated to slow the progress of ALS. We and many other ALS centers are actively involved in research to find new medications and therapies to treat ALS and its symptoms. Our ALS Clinic and Research Center participates in the Northeast ALS Consortium which has organized a number of clinical trials of new medications for ALS. Other studies may involve gathering and analyzing clinical information about you or the disease, or other kinds of interventions. We offer patients the opportunity to participate in these clinical trials when they meet the enrollment criteria for that particular study. Participation in any trial is entirely voluntary. You may decide not to participate or to withdraw at any time without losing the benefits of your standard medical care.
Basic and Translational ALS Research
UAMS is home to world-class ALS research within the Department of Neurobiology and Developmental Science in the College of Medicine. These efforts have been supported by local and NIH research grants as well as philanthropic contributions from many generous donors throughout the state of Arkansas.
Make a Donation
An honor or memorial gift to UAMS to support ALS care and research is a special way to remember a friend or family member. The honoree or deceased’s family member will receive an acknowledgement card. The amount is not disclosed on the card. Please provide the name and address of the person you are honoring and the person to whom we should send the acknowledgment card. You will receive a receipt for your tax-deductible contribution.
Donations can be sent to:
UAMS Foundation – ALS Research
Attention: Michael Legate
University of Arkansas for Medical Sciences
4301 W. Markham #500
Little Rock, AR 72205